Dr Jim Coward

Senior Research Fellow


About me

Dr Jim Coward is a medical oncology specialist in gynaecological malignancies and is a senior research fellow in the 'cancer therapeutics group' within the biological therapies program at Mater Research.

He completed his medical training at Imperial College, London in 1998 and became a member of the Royal College of Physicians in 2002. His interests in oncology began during his tenure as a junior doctor and he subsequently undertook specialist registrar training at Westmead Hospital, Sydney and the Royal Marsden Hospital, London. He has extensive experience in the development and conduct of Phase II clinical trials in addition to clinical management of numerous tumour types. In 2006, he was appointed as a MRC clinical fellow at the Barts Cancer Institute, London and investigated the effects of anti-IL-6 in advanced ovarian cancer which involved the successful translation of laboratory research into a clinical trial in patients with platinum resistant disease. This research culminated in the award of his PhD from Queen Mary, University London in 2010. Since then, he has been involved in a number of international collaborations with researchers at Peter MacCallum and MD Anderson cancer centres with a focus on investigating the role of inflammatory cytokine networks in ovarian cancer.

Jim aims to foster firm links between Mater Research and Mater with the remit of his research revolving around efficient translation of novel bench-side discoveries in cancer related inflammation into nimble combinatorial clinical trials.